These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 17869448

  • 1. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG.
    Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1496-501. PubMed ID: 17869448
    [Abstract] [Full Text] [Related]

  • 2. Symptom clusters in patients with newly-diagnosed brain tumors.
    Gleason JF, Case D, Rapp SR, Ip E, Naughton M, Butler JM, McMullen K, Stieber V, Saconn P, Shaw EG.
    J Support Oncol; 2007 Oct 01; 5(9):427-33, 436. PubMed ID: 18019850
    [Abstract] [Full Text] [Related]

  • 3. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL.
    J Clin Oncol; 2006 May 01; 24(13):2073-8. PubMed ID: 16648508
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
    Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D.
    J Pain Symptom Manage; 2009 Nov 01; 38(5):650-62. PubMed ID: 19896571
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 01; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 6. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
    Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C.
    J Clin Oncol; 2003 Dec 01; 21(23):4439-43. PubMed ID: 14645434
    [Abstract] [Full Text] [Related]

  • 7. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H.
    Am J Med; 2006 Feb 01; 119(2):167.e23-30. PubMed ID: 16443425
    [Abstract] [Full Text] [Related]

  • 8. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS.
    Hum Psychopharmacol; 2005 Mar 01; 20(2):97-104. PubMed ID: 15641125
    [Abstract] [Full Text] [Related]

  • 9. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW, Drake J, Milch RA, Brazeau DA, Skretny JA, Brazeau GA, Donnelly JP.
    J Pain Symptom Manage; 2012 Jan 01; 43(1):68-77. PubMed ID: 22208450
    [Abstract] [Full Text] [Related]

  • 10. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
    Mendonça DA, Menezes K, Jog MS.
    Mov Disord; 2007 Oct 31; 22(14):2070-6. PubMed ID: 17674415
    [Abstract] [Full Text] [Related]

  • 11. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE.
    J Clin Oncol; 2004 Dec 01; 22(23):4795-803. PubMed ID: 15570081
    [Abstract] [Full Text] [Related]

  • 12. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?
    Brown P, Clark MM, Atherton P, Huschka M, Sloan JA, Gamble G, Girardi J, Frost MH, Piderman K, Rummans TA.
    Am J Clin Oncol; 2006 Feb 01; 29(1):52-8. PubMed ID: 16462503
    [Abstract] [Full Text] [Related]

  • 13. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
    Delbari A, Salman-Roghani R, Lokk J.
    Eur Neurol; 2011 Feb 01; 66(1):7-13. PubMed ID: 21701174
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW, Moughan J, Knisely JP, Fox SW, Chakravarti A, Yung WK, Curran WJ, Robins HI, Brachman DG, Henderson RH, Mehta MP, Movsas B.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):71-8. PubMed ID: 18164829
    [Abstract] [Full Text] [Related]

  • 15. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
    Truong PT, Berthelet E, Lee JC, Petersen R, Lim JT, Gaul CA, Pai H, Blood P, Ludgate CM.
    Can J Urol; 2006 Jun 01; 13(3):3139-46. PubMed ID: 16813705
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE, Harman S, Baughman RP.
    Chest; 2008 May 01; 133(5):1189-95. PubMed ID: 18263672
    [Abstract] [Full Text] [Related]

  • 17. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E, El Osta B, Valero V, Driver LC, Pei BL, Shen L, Poulter VA, Palmer JL.
    J Clin Oncol; 2007 Aug 10; 25(23):3475-81. PubMed ID: 17687152
    [Abstract] [Full Text] [Related]

  • 18. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N, Rothenburg LS, Black SE, Ryan M, Liu BA, Busto UE, Lanctôt KL.
    J Clin Psychopharmacol; 2008 Jun 10; 28(3):296-301. PubMed ID: 18480686
    [Abstract] [Full Text] [Related]

  • 19. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemelä A, Trott GE, Lee E, Buitelaar JK.
    Biol Psychiatry; 2008 May 15; 63(10):981-9. PubMed ID: 18206857
    [Abstract] [Full Text] [Related]

  • 20. Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial.
    de Souza Fêde AB, Bensi CG, Trufelli DC, de Oliveira Campos MP, Pecoroni PG, Ranzatti RP, Kaliks R, Del Giglio A.
    Am J Clin Oncol; 2007 Aug 15; 30(4):432-6. PubMed ID: 17762445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.